Filters
Funding available: £60,000
Closing date:
Funding overview:

The MS Society Catalyst Award provides support over a maximum of 12 months for short-term, small-scale pilot or proof of concept research projects to explore innovative ideas in MS research. Projects should be hypothesis driven and may be 'high-risk, high-reward' in nature.

Learn more:

MS Society

Funding available: £15,000
Closing date:
Funding overview:

Grants to support early career researchers in the UK undertaking translational or proof of concept research in any area of gastroenterology (including pancreatology and hepatology).

Learn more:

Guts UK

Funding available: Discretionary
Closing date:
Funding overview:

Funding available to UK organisations and educational establishments for the funding of capital infrastructure in the fields of science and medicine, health, education and the arts and humanities.

Funding available: Discretionary
Closing date:
Funding overview:

Funding to enable researchers of Black, Bangladeshi and Pakistani heritage in the UK to undertake activities that put them in a stronger position to reach their next career stage.

Learn more:

Wellcome

Funding available: £3,500,000
Closing date:
Funding overview:

Projects should aim to develop new methodologies, frameworks, tools, or techniques that benefit health-related research. Proposals must align with Wellcome’s discovery research remit and can be single-discipline or multidisciplinary, spanning areas such as STEM, experimental medicine, clinical and allied health sciences, public health, humanities, and social sciences.

Learn more:

Wellcome

Funding available: Funding not specific
Closing date:
Funding overview:

The Health and Social Care Delivery Research (HSDR) Programme invites research proposals focused on hospital at home services (also referred to as virtual wards) for both adults and children or young people. This funding opportunity supports studies aimed at optimising service design, enhancing equity and delivery, assessing impacts on health and social care systems, and exploring innovative approaches to service integration.

Funding available: £99,000
Closing date:
Funding overview:

HIS offers research grants to support research projects in the field of healthcare-associated infections (HCAIs) and infection prevention and control in the UK or Ireland. The thematic focus is on translational research.

Funding available: £200,000
Closing date:
Funding overview:

Grants available for academics based at UK research institutions to enable them to develop novel drugs for the treatment of Parkinson's.

Learn more:

Parkinson's UK

Funding available: £200,000
Closing date:
Funding overview:

This award aims to accelerate and drive forward the development of novel drugs for the treatment of Parkinson's. The initiative should provide researchers with the opportunity to generate essential data and help bridge the gaps needed to get their projects/compounds ready to enter full scale drug discovery with an industry partner.

Learn more:

Parkinson's UK

Funding available: £1,000,000
Closing date:
Funding overview:

The Neurosciences and Mental Health Board (NMHB) seeks to advance understanding of the nervous system’s physiology and behaviour across the lifespan, in both health and disease, to improve treatment and prevention of brain disorders. Our research focuses on the connections between the nervous system, brain, mental health, and physical health, as well as how life events influence lifelong neurological and mental wellbeing.

Funding available: £200,000
Closing date:
Funding overview:

The Sarcoma UK grants programme funds scientific and medical research to investigate the mechanisms of all forms of bone and soft tissue cancers and develop more effective diagnostics and treatments. Its Research Strategy for 2021-2026 aims to ensure everyone affected by sarcoma receives the best treatment, care, information and support available and focuses on researching causes, diagnostics and treatment to improve quality of life, balanced across multiple sarcoma subtypes.

Learn more:

Sarcoma UK

Funding available: £10,000
Closing date:
Funding overview:

Funding available for projects, including clinical trials, pump priming projects, training and audits, aiming to raise the standards of breast care and breast surgery with clear value to the NHS.

Funding available: £100,000
Closing date:
Funding overview:

RAD's Ignition Fund provides seed funding for exceptional scientists specialising in dementia to support unexpected breakthroughs in their research. The awards are designed to enable scientists to rapidly exploit an opportunity and avoid promising ideas with high potential from being shelved.

The fund seeks to support innovative research that will facilitate a 'stage shift' towards dementia prevention, improved diagnosis, treatment and understanding of the fundamental science of the disease. Applicants do not need any preliminary data in order to apply, but smart and novel new ideas are particularly welcome.

Funding available: £100,000
Closing date:
Funding overview:

A funding model supported by the Vanguard Initiative, which is a collaborative programme supporting industrial modernisation and innovation through industry-led and cross-regional cooperation.

Funding available: Discretionary
Closing date:
Funding overview:

The Health and Social Care Delivery Research (HSDR) Programme seeks to fund high-quality, well-designed research that addresses the needs of NHS and social care leaders. Projects will be conducted by efficient and capable research teams. This is a two-stage, researcher-led funding opportunity. Applicants submit an outline application first; invited candidates then complete a full application at stage two.

Funding available: Funding not specific
Closing date:
Funding overview:

What is the feasibility, acceptability, effectiveness, and cost-effectiveness of newborn screening for spinal muscular atrophy (SMA)? An appropriately designed study to allow the evaluation of the addition of SMA screening to the newborn blood spot screening programme.

Funding available: Discretionary
Closing date:
Funding overview:

What is the clinical and cost-effectiveness of screening for asymptomatic bacteriuria (ASB) in pregnancy? A retrospective study assessing the impact of early pregnancy ASB screening. Applicants should include an internal pilot to confirm data collection feasibility and ensure study completion.

Funding available: £3,000,000
Closing date:
Funding overview:

The CRUK research funding programme awards a wide range of fellowships and grants to support researchers, across all career stages, conducting clinical, pre-clinical, discovery and translational research to advance the detection, diagnosis, treatment, and potential cure, of all forms of cancer.

Funding available: £74,186
Closing date:
Funding overview:

The ZOLL Foundation is a US-based 501(c)(3) non-profit organisation that was established in 2013 by the ZOLL Medical Corporation. The Foundation provides seed grants for young researchers around the world to support medical research that saves lives. Its scope encompasses a wide range of areas including, but not limited to, emergency medicine, critical care, trauma, cardiovascular health, pulmonary health, neuroscience, and translational research focused on applying discoveries to enhance training and delivery in clinical practice.

Learn more:

ZOLL Foundation

Funding available: £400,000
Closing date:
Funding overview:

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.

Learn more:

Wellcome

Funding available: £148,373
Closing date:
Funding overview:

Funding to support investigator-initiated studies and education projects, on molecular profiling in oncology and reproductive health, with the aim of increasing high quality molecular profiling for health care providers serving cancer patients and improving clinical outcomes.

Funding available: £12,500,000
Closing date:
Funding overview:

Research and Partnership Hubs for a Healthy Society will establish large, multidisciplinary hubs that harness engineering and physical sciences to build strategic research capacity in healthcare technologies. The aim is to support healthier lives through advances in prevention, early diagnosis, and self-management of health.

Funding available: Discretionary
Closing date:
Funding overview:

This Notice of Funding Opportunity (NOFO) supports pilot studies exploring the biological and genetic causes of cancer health disparities. Funding is available for mechanistic research, new models and methods, and secondary data analysis. The NOFO also aims to build a national network of researchers in this field and expand key resources like biospecimens and patient-derived models. Early-stage projects that lay the groundwork for future in-depth studies are encouraged.

Funding available: Funding not specific
Closing date:
Funding overview:

This Funding Opportunity Announcement (FOA) supports discrete, well-defined projects in any area of cancer research using the National Institutes of Health R03 small grant mechanism. The National Institutes of Health R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. Examples of the types of projects that the R03 grant mechanism include, but are not limited to, the following:  Pilot or feasibility studies.Secondary analysis of existing data.Small, self-contained research projects.Development of research methodology.Development of new research technology.

Funding available: $40,000
Closing date:
Funding overview:

Friends for an Earlier Breast Cancer Test (Earlier.org) is a US-based non-profit organisation, established in 1995, that is dedicated exclusively to funding research focused on developing innovative methods for the earlier detection of breast cancer. Its mission is to support the creation of a biological test capable of identifying breast cancer at its earliest stages, potentially even before a tumour has formed. Earlier.org provides funding to support pilot projects that explore new techniques for early breast cancer detection. Grants are intended to provide preliminary data that can lead to more substantial peer-reviewed funding.

Funding available: Funding not specific
Closing date:
Funding overview:

This Notice of Funding Opportunity (NOFO) invites mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites and contexts in which expectancy effects can be leveraged to improve cancer outcomes. Expectancies are defined in this context as beliefs about future outcomes, including one's response to cancer or cancer treatment. Expectancies can be evoked by social, psychological, environmental and systemic factors. Expectancy effects are the cognitive, behavioural and biological outcomes caused by expectancies. Expectancy effects can be generated by expectancies held by patients, clinicians, family members, caregivers and/or dyadic/social networks.

Funding available: Funding not specific
Closing date:
Funding overview:

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is inviting research projects that implement early phase (Phase 0, I and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Office of HIV and AIDS Malignancies (OHAM).  The proposed project must involve at least one clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs.